Xiaoting Shan
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- Advanced biosensing and bioanalysis techniques 2
- RNA Interference and Gene Delivery 2
-
- Nanoparticle-Based Drug Delivery 3
- Co-authors
- Yaping Li (8 shared papers)Nansha Gao (2 shared papers)Lin Mei (2 shared papers)Zimu Li (2 shared papers)Xiaowei Zeng (2 shared papers)Xiang Gong (2 shared papers)Zhiwen Zhang (1 shared paper)Jie Li (1 shared paper)
In The Last Decade
Xiaoting Shan
14 papers receiving 719 citations
Xiaoting Shan's Hit Papers
Peers
Comparison fields: 5 of 90
- Biomaterials 312
- Biomedical Engineering 377
- Pharmaceutical Science 48
- Molecular Medicine 28
- Surfaces, Coatings and Films 32
Countries citing papers authored by Xiaoting Shan
This map shows the geographic impact of Xiaoting Shan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoting Shan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoting Shan more than expected).
Fields of papers citing papers by Xiaoting Shan
This network shows the impact of papers produced by Xiaoting Shan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoting Shan. The network helps show where Xiaoting Shan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoting Shan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Current approaches of nanomedicines in the market and various stage of clinical translation Hit paper breakdown → | 2022 | 227 |
| 2 | 2020 | 190 | |
| 3 | 2021 | 173 | |
| 4 | 2023 | 30 | |
| 5 | 2024 | 24 | |
| 6 | 2021 | 20 | |
| 7 | Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer Hit paper breakdown → | 2025 | 16 |
| 8 | 2020 | 16 | |
| 9 | 2023 | 12 | |
| 10 | 2024 | 5 | |
| 11 | 2020 | 4 | |
| 12 | 2025 | 3 | |
| 13 | 2024 | 3 | |
| 14 | 2021 | 3 |
About Xiaoting Shan
Xiaoting Shan is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Immunology and Oncology, having authored 14 papers that have together received 726 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), RNA Interference and Gene Delivery (2 papers), Immune cells in cancer (2 papers), Semiconductor Quantum Structures and Devices (1 paper), Alzheimer's disease research and treatments (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Biomaterials (312 citations), Biomedical Engineering (377 citations), Pharmaceutical Science (48 citations), Molecular Medicine (28 citations) and Surfaces, Coatings and Films (32 citations). Xiaoting Shan has collaborated with scholars based in China, Norway and Taiwan. Frequent co-authors include Yaping Li, Nansha Gao, Lin Mei, Zimu Li, Xiaowei Zeng, Xiang Gong, Zhiwen Zhang, Jie Li, Jingyuan Wen and Wenfeng Zeng. Their work appears in journals such as Nature Communications, Advanced Healthcare Materials, Advanced Materials, Acta Pharmaceutica Sinica B and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.